atenolol has been researched along with Aortic Dissection in 4 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Long-term outcome of Marfan syndrome patients randomly assigned to losartan or atenolol showed no differences in aortic dilation rate or presence of clinical events between treatment groups." | 9.27 | Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome. ( Evangelista, A; Forteza, A; García-Dorado, D; González Mirelis, J; Gutiérrez, L; Ibáñez, B; Rodríguez-Palomares, J; Sánchez, V; Teixido-Tura, G, 2018) |
| "Long-term outcome of Marfan syndrome patients randomly assigned to losartan or atenolol showed no differences in aortic dilation rate or presence of clinical events between treatment groups." | 5.27 | Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome. ( Evangelista, A; Forteza, A; García-Dorado, D; González Mirelis, J; Gutiérrez, L; Ibáñez, B; Rodríguez-Palomares, J; Sánchez, V; Teixido-Tura, G, 2018) |
| " One of the twins suffered a type A aortic dissection, which required replacement of the ascending aorta, and the other twin had an aneurysmal dilatation of the ascending aorta (46mm) and was prescribed medical treatment with atenolol and periodic controls to detect the presence of a critical diameter (50mm) that would indicate the need for prophylactic surgery." | 3.74 | Monozygotic twins with Marfan's syndrome and ascending aortic aneurysm. ( Belforte, SM; Cianciulli, TF; Lax, JA; Picone, VP; Prezioso, HA; Recalde, B; Redruello, HJ; Rostello, EF, 2007) |
| "Acute-on-chronic type B aortic dissection, complicated by aneurysmal dilatation of the thoracic aorta and visceral malperfusion." | 1.33 | Staged endovascular treatment for complicated type B aortic dissection. ( Amukotuwa, SA; McLachlan, CS; Mossop, PJ; Nixon, IK, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teixido-Tura, G | 1 |
| Forteza, A | 1 |
| Rodríguez-Palomares, J | 1 |
| González Mirelis, J | 1 |
| Gutiérrez, L | 1 |
| Sánchez, V | 1 |
| Ibáñez, B | 1 |
| García-Dorado, D | 1 |
| Evangelista, A | 1 |
| Mossop, PJ | 1 |
| McLachlan, CS | 1 |
| Amukotuwa, SA | 1 |
| Nixon, IK | 1 |
| Redruello, HJ | 1 |
| Cianciulli, TF | 1 |
| Rostello, EF | 1 |
| Recalde, B | 1 |
| Lax, JA | 1 |
| Picone, VP | 1 |
| Belforte, SM | 1 |
| Prezioso, HA | 1 |
| Jondeau, G | 1 |
| Barthelet, M | 1 |
| Baumann, C | 1 |
| Bonnet, D | 1 |
| Chevallier, B | 1 |
| Collignon, P | 1 |
| Dulac, Y | 1 |
| Edouard, T | 1 |
| Faivre, L | 1 |
| Germain, D | 1 |
| Khau Van Kien, P | 1 |
| Lacombe, D | 1 |
| Ladouceur, M | 1 |
| Lemerrer, M | 1 |
| Leheup, B | 1 |
| Lupoglazoff, JM | 1 |
| Magnier, S | 1 |
| Muti, C | 1 |
| Plauchu, PH | 1 |
| Raffestin, B | 1 |
| Sassolas, F | 1 |
| Schleich, JM | 1 |
| Sidi, D | 1 |
| Themar-Noël, C | 1 |
| Varin, J | 1 |
| Wolf, JE | 1 |
1 trial available for atenolol and Aortic Dissection
| Article | Year |
|---|---|
Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin II Type 1 Receptor Blockers; Aorta; Aorti | 2018 |
3 other studies available for atenolol and Aortic Dissection
| Article | Year |
|---|---|
Staged endovascular treatment for complicated type B aortic dissection.
Topics: Acute Disease; Adult; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Atenolol; Back | 2005 |
Monozygotic twins with Marfan's syndrome and ascending aortic aneurysm.
Topics: Adult; Aorta; Aortic Aneurysm; Aortic Dissection; Atenolol; Humans; Male; Marfan Syndrome; Twins, Mo | 2007 |
[Recommendations for the medical management of aortic complications of Marfan's syndrome].
Topics: Adrenergic beta-Antagonists; Aortic Aneurysm; Aortic Dissection; Atenolol; Bisoprolol; Calcium Chann | 2006 |